Satellite Biosciences

BiotechnologySeries ACambridge, USsatellite.bio

Latest round

Series A

Last raised

Feb 2022

Total raised

$102M

Investors

7

About Satellite Biosciences

Satellite Biosciences, Inc.Founded in 2019 and headquartered in Cambridge, US, Satellite Biosciences, Inc. develops advanced cellular therapies. The firm was co-founded by Arnav Chhabra, Christopher Chen, and Sangeeta Bhatia, with Dave Lennon as the CEO.Satellite Biosciences focuses on innovative delivery of living cells through its Tissue Therapeutics offerings, primarily the Satellite™ Adaptive Tissue (SAT) Platform. This platform enhances the engraftment and functionality of expanded, mature hepatocyte cells, utilizing technological advancements in expansion, seed formation, and stabilization to address severe diseases.Satellite Biosciences generates revenue through strategic partnerships with healthcare institutions, engaging in B2B transactions to provide advanced cellular therapies. The company is also targeting expansion into new geographic markets in Europe and Asia by 2024, to enhance the availability of their cellular therapies. These initiatives aim to strengthen their position in the regenerative medicine landscape and broaden access to their innovative solutions.

Who invested in Satellite Biosciences

7 investors across 2 rounds

See all investors in Satellite Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 25, 2022

    Amount

    $83M

    Investors

    Locked

  2. Seed

    Nov 2, 2020

    Amount

    $19M

    Investors

    Locked

Questions about Satellite Biosciences

Who invested in Satellite Biosciences?

Satellite Biosciences has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Satellite Biosciences raised?

Satellite Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Satellite Biosciences last raise money?

Satellite Biosciences's most recent round on record is a Series A, in Feb 2022.

What does Satellite Biosciences do?

Satellite Biosciences is a biotechnology company.

Where is Satellite Biosciences headquartered?

Satellite Biosciences is headquartered in Cambridge, US.

Which VCs invest in companies like Satellite Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Satellite Biosciences's stage. Their profiles are linked below.

Raising like Satellite Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.